![]() |
A promising new approach to blocking Abeta toxicity
|
I read the BBC News Report about this. It does look interesting.
Dave. |
Dave, it does indeed look interesting.
One good thing is that bexarotene has FDA approval as a cancer chemotherapeutic which means that the basic (Phase 1 clinical trials) checking will have been done. So, with luck and more work (if it checks out) it might be possible to introduce it as an AD treatment fairly soon. |
All times are GMT -5. The time now is 01:05 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.